Overview

In this issue of Surgical Oncology Clinics, guest editor Dr. Genevieve Boland brings her considerable expertise to the topic of Melanoma. Top experts provide a timely update on management of melanoma, with articles on nodal management, stage 4 surgery, margins, systemic therapy, and neoadjuvant therapy, as well as vaccines in melanoma and ocular and mucosal melanoma. Contains 10 relevant, practice-oriented topics including margins for melanoma: alternative approaches (Mohs), extent of resection (lentigo maligna MIS, SSM, Melmart), and future considerations; age and gender correlations with melanoma outcomes; systemic therapy for melanoma: what surgeons need to know; is nodal staging needed, what is the value, and what is the extent of surgery?; and more Provides in-depth clinical reviews on melanoma, offering actionable insights for clinical practice Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews

Full Product Details

Author:   Genevieve Boland, MD, PhD (Vice Chair of Research, Department of Surgery, Mass General Surgery: Surgical Oncology, Yawkey Center for Outpatient Care, Boston, MA, USA)
Publisher:   Elsevier Health Sciences
Imprint:   Churchill Livingstone
Weight:   0.450kg
ISBN:  

9780443317606

ISBN 10:   0443317607
Pages:   240
Publication Date:   28 July 2025
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Margins for Melanoma: Extent of Resection, Alternative Approaches, and Future Considerations Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions) Nodal Management in Melanoma: Is Nodal Staging Needed, What Is the Value, and What Is the Extent of Surgery? Systemic Therapy for Melanoma: What Surgeons Need to Know Neoadjuvant Therapy: Changes in the Management of Macroscopic Stage III/ Resectable Stage IV Melanoma Management of In-transit Disease: Regional Therapies, Intralesional Therapies, and Systemic Therapy Vaccines in Melanoma: Past, Present, and Future Adoptive T-Cell Therapy in Melanoma: How This Will Impact Surgical Practice and the Role of Surgeons Predictive Biomarkers for Immune Checkpoint Inhibitor Therapy in Advanced Melanomas Non-Cutaneous Melanoma: Biology, Clinical Management, Current Therapy, and Future Directions in Treatment

Reviews

Author Information

Tab Content 6

Author Website:  

Countries Available

All regions